Trump Announces Plan to Cut Ozempic Prices

Multiple credible sources directly corroborate the statement. A Reuters headline (Source 11) states, 'Trump calls out weight-loss drugs as target of price-cut push,' and the article mentions GLP-1s, the class of drugs that includes Ozempic. Additionally, a legal analysis firm (Source 13) notes that Trump's executive orders impact health care by seeking to 'lower prices for those drugs, including Ozempic and Wegovy.' The New York Times (Source 5) also mentions Ozempic in the context of Trump's drug pricing plans. The evidence strongly supports that a plan was announced with Ozempic as a target.